Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06591559 · ClinicalTrials.gov registry record · NA
Up, Down, and All Around: Evaluating Mobility Devices for Young Children With Developmental Disabilities and Delays
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT06591559: Completed NA study, sponsored by University of Washington.
NCT06591559 is a NA study that has completed, run by University of Washington. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06591559, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This research study will examine young children with Down syndrome's initial experiences with mobility devices. Children's biomechanics and exploration will be quantified while they are using both an overground partial bodyweight support system and powered mobility device.
Primary Outcome
The path of each child's movement during the play sessions will be tracked from video recordings and sensor data. The path will then be used to determine the percentage of the available play space that the child explored. Values will range from 0 - 100%, a higher value indicates more space explored.
Interventions
- DEVICE Permobil Explorer Mini
- DEVICE Portable Mobility Aid for Children (PUMA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-02-11 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What the finished NCT06591559 record still lists
NCT06591559 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Permobil Explorer Mini is the first listed.
NCT06591559 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06591559 about?
NCT06591559 is a clinical study titled "Up, Down, and All Around: Evaluating Mobility Devices for Young Children With Developmental Disabilities and Delays". This research study will examine young children with Down syndrome's initial experiences with mobility devices. Children's biomechanics and exploration will be quantified while they are using both an overground partial bodyweight support system and powered mobility device.
What is the current status of trial NCT06591559?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2025-02-11. Estimated completion is 2026-03-30.
What interventions are being tested in trial NCT06591559?
The interventions under investigation include: Permobil Explorer Mini (DEVICE), Portable Mobility Aid for Children (PUMA) (DEVICE).
Who is sponsoring clinical trial NCT06591559?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06591559's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI